SLC9A3 and metabolic syndrome: Blocking or inhibiting the main carbohydrate-stimulated salt absorbing molecules in the small intestine (NHE3, PAT1, and SGLT) and kidney tubules (NHE3, NCC, and ENaC) may significantly blunt the generation of hypertension in individuals with metabolic syndrome.